{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:58:45Z","timestamp":1791421125820,"version":"4.3.3"},"reference-count":39,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.2967\/jnumed.116.178889","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T22:13:56Z","timestamp":1470348836000},"page":"75-80","source":"Crossref","is-referenced-by-count":165,"title":["Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results"],"prefix":"10.2967","volume":"58","author":[{"given":"Berthold A.","family":"Nock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Kaloudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Lymperis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Giarika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad R.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Klette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviral","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Krenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodosia","family":"Maina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"2021051712101064000_58.1.75.1","first-page":"1152","article-title":"Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation","volume":"59","author":"Markwalder","year":"1999","journal-title":"Cancer Res."},{"key":"2021051712101064000_58.1.75.2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22743"},{"key":"2021051712101064000_58.1.75.3","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21434"},{"key":"2021051712101064000_58.1.75.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65525-3"},{"key":"2021051712101064000_58.1.75.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-0794-5"},{"key":"2021051712101064000_58.1.75.6","first-page":"280","article-title":"Characterization of bombesin\/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression","volume":"55","author":"Halmos","year":"1995","journal-title":"Cancer Res."},{"key":"2021051712101064000_58.1.75.7","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2006.0025"},{"key":"2021051712101064000_58.1.75.8","doi-asserted-by":"publisher","DOI":"10.2174\/1381612811319180015"},{"key":"2021051712101064000_58.1.75.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.064444"},{"key":"2021051712101064000_58.1.75.10","doi-asserted-by":"publisher","DOI":"10.1021\/jm049437y"},{"key":"2021051712101064000_58.1.75.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-006-0347-4"},{"key":"2021051712101064000_58.1.75.12","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991126)83:5<657::AID-IJC15>3.0.CO;2-Y"},{"key":"2021051712101064000_58.1.75.13","doi-asserted-by":"publisher","DOI":"10.1021\/jm300741f"},{"key":"2021051712101064000_58.1.75.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.118695"},{"key":"2021051712101064000_58.1.75.15","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1021\/jm4010237","article-title":"Tumor diagnosis with new 111In-radioligands based on truncated human gastrin releasing peptide sequences: synthesis and preclinical comparison","volume":"56","author":"Marsouvanidis","year":"2013","journal-title":"J Med Chem."},{"issue":"suppl 2","key":"2021051712101064000_58.1.75.16","first-page":"S221","article-title":"177Lu-AMBA bombesin analogue in hormone refractory prostate cancer patients: a phase I escalation study with single-cycle administrations","volume":"34","author":"Bodei","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712101064000_58.1.75.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.045054"},{"key":"2021051712101064000_58.1.75.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-1040-x"},{"key":"2021051712101064000_58.1.75.19","doi-asserted-by":"publisher","DOI":"10.7150\/thno.7324"},{"key":"2021051712101064000_58.1.75.20","doi-asserted-by":"publisher","DOI":"10.1021\/jm5012066"},{"key":"2021051712101064000_58.1.75.21","doi-asserted-by":"publisher","DOI":"10.1021\/jm301692p"},{"key":"2021051712101064000_58.1.75.22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7150\/thno.13580","article-title":"In vivo stabilization of a gastrin-releasing peptide receptor antagonist enhances PET imaging and radionuclide therapy of prostate cancer in preclinical studies","volume":"6","author":"Chatalic","year":"2016","journal-title":"Theranostics."},{"key":"2021051712101064000_58.1.75.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3232-1"},{"issue":"suppl 2","key":"2021051712101064000_58.1.75.24","first-page":"S319","article-title":"Transient in vivo NEP inhibition enhances the theranostic potential of the new GRPR-antagonist [111In\/177Lu]SB","volume":"41","author":"Lymperis","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712101064000_58.1.75.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1596-9"},{"key":"2021051712101064000_58.1.75.26","doi-asserted-by":"publisher","DOI":"10.1021\/jm00111a027"},{"key":"2021051712101064000_58.1.75.27","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990250105"},{"key":"2021051712101064000_58.1.75.28","unstructured":"Dalm SU Bakker I de Blois E . NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use. J Nucl Med. September 8, 2016 [Epub ahead of print]."},{"key":"2021051712101064000_58.1.75.29","doi-asserted-by":"publisher","DOI":"10.7150\/thno.3931"},{"key":"2021051712101064000_58.1.75.30","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2012.01.002"},{"key":"2021051712101064000_58.1.75.31","doi-asserted-by":"publisher","DOI":"10.7150\/thno.4024"},{"key":"2021051712101064000_58.1.75.32","doi-asserted-by":"publisher","DOI":"10.1021\/ar800188e"},{"key":"2021051712101064000_58.1.75.33","first-page":"823","article-title":"Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs","volume":"46","author":"Maina","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712101064000_58.1.75.34","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.065706"},{"issue":"suppl 1","key":"2021051712101064000_58.1.75.35","first-page":"S125","article-title":"A novel gallium-68-labelled GRP receptor antagonist, [68Ga]sarabesin 3, for prostate cancer imaging: first results in therapy na\u00efve primary patients","volume":"42","author":"Bakker","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712101064000_58.1.75.36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1569-9056(16)60569-9","article-title":"PET imaging of therapy-na\u00efve primary prostate cancer patients using the GRPr-targeting ligand sarabesin 3 [abstract]","volume":"15","author":"Bakker","year":"2016","journal-title":"Eur Urol Suppl."},{"key":"2021051712101064000_58.1.75.37","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11307-014-0754-z","article-title":"GRP receptor imaging of prostate cancer using [99mTc]Demobesin 4: a first-in-man study","volume":"16","author":"Mather","year":"2014","journal-title":"Mol Imaging Biol."},{"key":"2021051712101064000_58.1.75.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2013.09.003"},{"key":"2021051712101064000_58.1.75.39","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.168393"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.116.178889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:13:18Z","timestamp":1621267998000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.116.178889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,3]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.2967\/jnumed.116.178889"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.116.178889","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}